| VIII Zjazd Polskiego Towarzystwa Tyreologicznego SESJA 1. CHOROBY TARCZYCY U DOROSŁYCH I U DZIECI Moderatorzy: prof. dr hab. Artur Bossowski / prof. dr hab. Agata Bałdys-Waligórska |
||
| Lp. | Tytuł pracy | Autor prezentujący |
| 1.01 | Zastosowanie zjawiska autofluorescencji przytarczyc do śródoperacyjnej identyfikacji i ochrony podczas zabiegów resekcji tarczycy u dzieci. | Dariusz Polnik |
| 1.02 | Neurological aspects of thyroid dysfunction | Jerzy S. Tarach |
| 1.03 | Continuous intraoperative neuromonitoring in pediatric thyroid surgery | Anna Taczanowska-Niemczuk |
| 1.04 | Practical guidance in the management of endocrine immune-related adverse events in cancer immunotherapy | Agnieszka Zwolak |
| 1.05 | Radioactive iodine therapy (RAI) for Graves‘ disease (GD) in children up to 15 years old. | Aleksandra Król |
| 1.06 | THYROID CANCER IN CHILDREN - 24 YEARS OF EXPERIENCE FROM ONE CENTER | Magdalena Tarasińska |
| 1.07 | Analysis of miR-15a-5p, miR-126-3p and miR-142-5p levels in blood of children and adolescents with thyroid diseases | Artur Bossowski |
| 1.08 | Postoperative histopathological findings in thyroid nodules classified as Bethesda III category in children | Anna Taczanowska-Niemczuk |
| 1.09 | Effects of therapy on Th1, Th17, Th22 and Bregs in pediatric patients with Graves’ disease | Karolina Stożek |
| 1.10 | Machine learning risk prediction for thyroid nodules malignancy | Magdalena Kamińska |
| 1.11 | The Application of Ultrasound Elastography in Combination with Ultrasound-based Risk Stratification Systems in Diagnosis of Malignant Thyroid Nodules in Children and Adoles-cents—Retrospective Analysis of One Center | Artur Bossowski |
| 1.12 | Thyrotoxic psychosis – a case report of acute psychosis related to autoimmune thyroiditis | Monika Lenart-Lipińska |
| II Zjazd Polskiego Towarzystwa Endokrynologii Onkologicznej SESJA 2. GUZY NEUROENDOKRYNNE I INNE RZADKIE NOWOTWORY GRUCZOŁÓW WYDZIELANIA WEWNĘTRZNEGO Moderatorzy: dr hab. Agnieszka Gilis-Januszewska / dr n. med. Elżbieta Andrysiak-Mamos |
||
| Lp. | Tytuł pracy | Autor prezentujący |
| 2.01 | Well-differentiated gastroenteropancreatic G3 NET: clinical characteristics, treatment and outcomes - personalized approach. | Marta Opalińska |
| 2.02 | Radioembolization of Neuroendocrine Neoplasms Liver Metastases: Efficacy and Early Toxicity | Michal Gola |
| 2.03 | Pembrolizumab in advanced, inoperable or metastatic adrenocortical carcinoma after first line chemotherapy failure – Medical Research Agency project – right before recruiting. | Agnieszka Kotecka-Blicharz |
| 2.04 | Clinical course of parathyroid carcinoma based on own experience | Barbara Michalik |
| 2.05 | Own experience in the treatment of parathyroid cancer | Barbara Michalik |
| 2.06 | Corrected SUVmax change as a prognostic factor of response to PRRT | Marta Opalińska |
| 2.07 | How clear cell renal cell carcinoma imitated metastatic neuroendocrine neoplasm – case report. | Igor Syrenicz |
| 2.08 | The role of immunohistochemical staining of appendiceal neuroendocrine neoplasms. | Dariusz Starzyński |
| II Zjazd Polskiego Towarzystwa Endokrynologii Onkologicznej SESJA 3 - WSPÓŁPRACA INTERDYSCYPLINARNA MIĘDZY ENDOKRYNOLOGAMI I ONKOLOGAMI Moderatorzy: dr med. Joanna Januszkiewicz-Caulier / prof. dr hab. Krzysztof Sworczak |
||
| Lp. | Tytuł pracy | Autor prezentujący |
| 3.01 | From obesity to cancer - what do we know about pathomechanisms and what can we do with this knowledge? | Agnieszka Zwolak |
| 3.02 | Causes of hypocalcemia in cancer patients. A rare case of severe sequestration hypocalcemia in a patient with metastatic breast cancer. | Ewa Tywanek |
| 3.03 | Sleep quality correlates with various aspects of quality of life in pituitary adenoma patients | Karol Sagan |
| 3.04 | Diagnostic dilemmas in patient with postmenopausal hyperandrogenization | Elżbieta Sowińska-Przepiera |
| 3.05 | Adrenocortical carcinoma in the pregnancy | Elżbieta Sowińska-Przepiera |
| 3.06 | Cancer immunotherapy-induced endocrinopathies: a single centre experience | Iwona Pałyga |
| 3.07 | Results of long-term observation for late endocrine effects in childhood cancer survivors | Joanna Smyczyńska |
| 3.08 | The association between thyroid malignancy and Hashimoto’s disease in a single institution | Mateusz Bereza |
| 3.09 | Etomidate infusion in the management of severe hypercortisolemia in the course of ACTH-etopic production by small-cell lung carcinoma - a case report | Joanna Świrska |
| 3.10 | Severe hypokalemia due to secondary mineralocorticoid excess syndrome (MCES) following abiraterone therapy in a patient with prostate cancer. A case report. | Marcin Lewicki |
| 3.11 | Targeted magnetic resonance of the ovaries in the diagnosis of severe hyperandrogenaemia in postmenopausal woman – a case report | Magdalena Stasiak |
| 3.12 | The role of mitotane concentration monitoring in the treatment of adrenal carcinoma - experience from the Gliwice center | Sylwia Szpak-Ulczok |
| VI Konferencja „Rak Tarczycy” SESJA 4 - PATOGENEZA I KLINIKA RAKA TARCZYCY U DOROSŁYCH I U DZIECI Moderatorzy: prof. dr hab. Dorota Pach / dr hab. Anna Kucharska |
||
| Lp. | Tytuł pracy | Autor prezentujący |
| 4.01 | Malignant Neoplasms of Thyroid - Own Experience | Krzysztof Kaczka |
| 4.02 | Changes in clinical presentation of differentiated thyroid cancer in children in 40-year experience of Department of Nuclear Medicine and Oncological Endocrinology in Gliwice | Aleksandra Kropińska |
| 4.03 | Radioiodine treatment after thyroid hormone withdrawal or rhTSH stimulation- a single centre retrospective study in metastatic differentited thyroid cancer in pediatric patients | Aleksandra Kropińska |
| 4.04 | Does Hashimoto’s affect the course of papillary thyroid cancer? Based on patients group with high incidence of HT in PTC. | Andrzej Hellmann |
| 4.05 | Review of thyroid cancer patients admitted in a tertiary reference center in 2020 | Magdalena Kołton |
| 4.06 | The influence of coexistence of Graves’ disease on staging and clinicopathological characteristic of patients with differentiated thyroid carcinoma | Łukasz Nawacki |
| 4.07 | The influence of coexistence of Hashimoto thyroiditis (HT) on staging and clinicopathological characteristic of patients with differentiated thyroid carcinoma (DTC) | Iwona Pałyga |
| 4.08 | Papillary carcinoma and thyrotoxicosis - “red flag” symptoms. The clinical study of two children. | Anna Kucharska |
| 4.09 | Prevalence of thyroid cancer in children with Graves’ disease treated in the Department of Pediatric Endocrinology and Rheumatology in Poznan, Poland (2005-2018) | Maciej Flader |
| 4.10 | Malignant neoplasms of the thyroid gland in children and adolescents treated surgically - 50 years of experience | Jerzy Harasymczuk |
| 4.11 | Effect of concentration leptin and insulin on clinicopathological characteristic of differentiated thyroid cancer (DTC) - analysis of 675 cases. | Estera Mikina |
| 4.12 | GLP-1 receptor agonists and a risk of thyroid cancer- a review of current knowledge | Olga Wajtryt |
| 4.13 | Otyłość jako potencjalny czynnik ryzyka raka tarczycy – badanie wstępne | Ewa Kiszczak-Bochyńska |
| VI Konferencja „Rak Tarczycy” SESJA 5 - DIAGNOSTYKA PRZED- I POOPERACYJNA RAKA TARCZYCY Moderatorzy: Prof. dr hab. Marek Dedecjus / Prof. dr hab. Janusz Dzięcioł |
||
| Lp. | Tytuł pracy | Autor prezentujący |
| 5.01 | Collision tumours of the thyroid – experience of a referral centre | Patrycja Sordoń |
| 5.02 | Association of preoperative serum TSH level with thyroid cancer in patients with AUS/FLUS thyroid tumor diagnosis. | Krzysztof Kaliszewski |
| 5.03 | Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 3879 patients. | Agnieszka Suligowska |
| 5.04 | Does it correct to approach NIFTP as a variant characterized by noninvasive features? | Kinga Hińcza-Nowak |
| 5.05 | The risk of malignancy in Bethesda IV thyroid nodules in Poland is low - time to slow down the rush to surgery | Piotr Wiśniewski |
| 5.06 | Core needle biopsy of the thyroid- diagnostic rescue or unnecessary risk? | Elwira Bakuła-Zalewska |
| 5.07 | Microcarcinoma of thyroid gland in patients with FNAB verified as follicular lesion of undetermined significance. | Jarosław Świrta |
| 5.08 | The Thyroid Bethesda – ten years’ experience | Juliusz Pankowski |
| 5.09 | Neck ultrasonography in the estimation of treatment effectiveness and in monitoring of thyroid cancer patients in the era of EBM. | Joanna Januszkiewicz-Caulier |
| 5.10 | Clinical diagnostic value of contrast-enhanced ultrasound (CEUS) in differential diagnosis of thyroid nodules – own experience | Agnieszka Żyłka |
| 5.11 | The prevalence of the cytological category in the Polish population according to Bethesda in a material from ultrasound guided fine-needle aspiration biopsy of the thyroid gland (FNAB) with preliminary material evaluation using an LED lamp | Dariusz Lange |
| 5.12 | EU-TIRADS Classification for the differential diagnosis of Bethesda Category IV | Agnieszka Żyłka |
| 5.13 | Paucicellular smears – does it always mean non diagnostic? | Juliusz Pankowski |
| 5.14 | Papillary thyroid cancer- T1 and nodal metastases in the results of histopathological examinations. | Lech Pomorski |
| 5.15 | Thyroid tumors of uncertain malignant potential according to WHO classification. | Ewa Zembala-Nożyńska |
| VI Konferencja „Rak Tarczycy” SESJA 6 - DIAGNOSTYKA MOLEKULARNA W RAKU TARCZYCY Moderatorzy: prof. dr hab. Katarzyna Łącka / dr hab. n. med. Małgorzata Oczko-Wojciechowska |
||
| Lp. | Tytuł pracy | Autor prezentujący |
| 6.01 | Znaczenie profilu ekspresji miRNA w diagnostyce raka brodawkowatego tarczycy | Mariusz Rogucki |
| 6.02 | Familial non-medullary thyroid cancer (FNMTC) - does the number of alanine residues in the FOXE1 gene matter? | Bartosz Domagała |
| 6.03 | The presence of concomitant BRAFV600E and TERT mutations do not affect the clinical outcome of papillary thyroid microcarcinoma | Artur Kuchareczko |
| 6.04 | FRMD5: a new player in molecular biology of papillary thyroid carcinoma | Agata M. Gaweł |
| 6.05 | hMTH1 protein interactome revealed using BioID method in normal SV40-transformed thyroid cells. | Katarzyna Arczewska |
| 6.06 | Analysis of the role of the HMGB1 in papillary carcinoma cells. | Małgorzata Grzanka |
| 6.07 | Elucidation of the role of podoplanin in papillary carcinoma using NGS-based assay | Ewa Gajda |
| 6.08 | Polymorphisms associated with Thyroid-Stimulating Hormone levels predispose to Papillary Thyroid Carcinoma | Jarosław Jendrzejewski |
| 6.09 | Prevalence of thyroid cancer in patients with multinodular goiter and DICER1 pathogenic variant | Marek Niedziela |
| 6.10 | TGF β and differentiated thyroid cancer | Adam Bednarczyk |
| 6.11 | The behavior of TGF β in patients operated on for nodular goiter, and obesity. | Adam Bednarczyk |
| 6.12 | A rapid course of papillary thyroid carcinoma in patients with genetic susceptibility | Magdalena Stasiak |
| VI Konferencja „Rak Tarczycy” SESJA 7 - OPERACJE W RAKU TARCZYCY I TECHNIKI ALTERNATYWNE LECZENIA MIEJSCOWEGO Moderatorzy: prof. dr hab. Lech Pomorski / dr med. Zbigniew Wygoda |
||
| Lp. | Tytuł pracy | Autor prezentujący |
| 7.01 | Ultrasound-guided laser ablation of euthyroid benign thyroid nodules: preliminary results at six months in 144 patients | Marcin Barczyński |
| 7.02 | A randomized controlled trial comparing near infrared autofluorescence technology with visual identification of parathyroid glands in the prevention of postoperative hypoparathyroidism: an interim safety analysis of a single recruiting center in a multicenter study | Marcin Barczyński |
| 7.03 | Radioguided occult lesion localization (ROLL) technique in patients with thyroid cancer relapse. | Grzegorz Woźniak |
| 7.04 | Stereotactic radiotherapy for thyroid cancer – When the surgeon can’t help. | Aleksandra Kukulska |
| 7.05 | Lobectomy for the treatment of thyroid cancer - outcomes of implementation of the 2018 Polish consensus in a single center. | Maciej Śledziński |
| 7.06 | Thyroid lobectomy as a diagnostic and therapeutic procedure – critical analysis of five hundred operations | Piotr Góralski |
| 7.07 | Transcervical Extended Mediastinal Lymphadenectomy in lymph node metastses of thyroid cancer - a single institution experience. | Jarosław Świrta |
| VI Konferencja „Rak Tarczycy” SESJA 8 - LECZENIE ZAAWANSOWANEGO RAKA TARCZYCY – RADIOJOD I FARMAKOTERAPIA UKIERUNKOWANA NA CELE MOLEKULARNE. PROBLEMY ZWIĄZANE Z LECZENIEM RAKA RDZENIASTEGO TARCZYCY. Moderatorzy: dr hab. Jolanta Krajewska / dr hab. Rafał Czepczyński |
||
| Lp. | Tytuł pracy | Autor prezentujący |
| 8.01 | Prospective, observational study on radioiodine treatment in DTC patients with intermediate risk or micro lymph node metastases | Aleksandra Blewązka |
| 8.02 | The intensity of the oxidative stress measurements in patients with differentiated thyroid cancer undergoing radioiodine therapy | Angelika Buczyńska |
| 8.03 | CD276 as important candidate for immunotherapy in medullary thyroid cancer | Kinga Hińcza-Nowak |
| 8.04 | Specification of psychological functioning of patients taking part in clinical research on new medications in advanced thyroid cancer therapy. | Anna Syska-Bielak |
| 8.05 | Is there genetic predisposition for medullary thyroid cancer in RET Y791T variant carriers? | Magdalena Kołton |
| 8.06 | Neurological rehabilitation as an integral part of the therapeutic process of patients with thyroid cancer | Sylwia Jezierska |
| 8.07 | Unexpected 131-I iodine scintigraphy finding | Aleksandra Aulich |
| 8.08 | Vandetanib in real-life practice – a retrospective evaluation of the Polish cohort | Jolanta Krajewska |
| 8.09 | Metastatic differentiated thyroid cancer – effectiveness of radioiodine treatment after recombinant human TSH (rhTSH) stimulation | Ewa Paliczka-Cieślik |
| 8.10 | Grading systems of medullary thyroid carcinoma in hereditary and sporadic tumors. | Ewa Chmielik |
| 8.11 | Dosimetric evaluation of I-131 treatment in patients with differentiated thyroid carcinoma - standardization of the data collection method | Aneta Kluczewska-Gałka |
| VI Konferencja „Rak Tarczycy” SESJA 9 - KAZUISTYKA RAKA TARCZYCY Moderatorzy: dr Aleksandra Kropińska / dr Iwona Pałyga |
||
| Lp. | Tytuł pracy | Autor prezentujący |
| 9.01 | Metastasis of breast cancer to the thyroid gland 20 years after a diagnosis of the primary disease – a case report | Agnieszka Florczak |
| 9.02 | Thyroid-type carcinoma in ovarian teratoma: a challenge for researchers and clinicians - report of five cases | Paulina Godlewska |
| 9.03 | Follicular thyroid carcinoma in the struma ovarii : a case report. | Tomasz Trybek |
| 9.04 | Papillary thyroid cancer (PTC) 18 years after treatment with Large B- cell lymphoma (LBCL) -a case report | Estera Mikina |
| 9.05 | Neoadjuvant treatment with radioactive iodine (131I) of a patient with inoperable papillary thyroid cancer (PTC) and distant metastases- a case report. | Aleksander Toś |
| 9.06 | Benign metastasizing leiomyoma in patient with oncological history – case report | Anna Brzeska |
